Morus alba root extract (MARE) has been used to treat hyperglycaemic conditions in oriental medicine. Here, we studied whether MARE possesses a cytotoxic effect on neuroblastoma. To check the cytotoxicity generated by MARE was whether relatively higher against the cancer cells rather than normal cells, we chose a neuroblastoma cell line (B103) and a normal cell line (Rat-2). A CCK assay revealed that MARE (10 Pg/ml) reduced cell viability to approximately 60% compared to an untreated control in B103 cells. But in Rat-2 cells, MARE induced relatively lower cytotoxicity. To investigate the mechanisms underlying the cytotoxic effect of MARE, we used flow cytometry combined with immunoblot analyses. We found that MARE-treatment could accumulate ROS and depolarize mitochondria membrane potential of B103 cells. Further treatment with MARE in B103 cells also could damage DNA and induce apoptosis. An expression study of p-Akt also suggested that there was a reduction in cellular proliferation and transcription along with the process of apoptosis, which was further evidenced by an increase in Bax and cleaved-caspase 3 activity. Together, our findings suggest that MARE produces more cytotoxicity in cancer cells while having a relatively attenuated effect on normal cells. As such, MARE may be a safer option in cancer therapeutics, and it also shows potential for the patients with symptoms of hyperglycemia and cancer.
INTRODUCTION
1 the overall incidence of childhood cancer burden is increasing progressively. The orthodox medicines and treatments do not bring any curative to the neuroblastoma patients. Neuroblastoma is a type of childhood cancer where the malignancy develops in immature nerve cells (Friedman and Castleberry, 2007) . It commonly arises in and around the adrenal glands (Nuchtern, 2006) , which have similar origins to nerve cells and in the abdomen, chest, neck, and spine (Fish and Grupp, 2008) . Currently, chemotherapy and radiation therapy are the most commonly used therapeutic approaches against neuroblastoma (Haase et al., 1999; Johnson et al., 2007) . These non-targeted therapeutic approaches have severe side-effects because they target and destroy all rapidly growing cells (Lastowska et al., 2001) . It is also crucial to find an inexpensive treatment so that it can be accessible to a greater number of individuals. Ancient medical literature reports the use of natural, plant-derived products, which have been found to be beneficial to cancer treatment, such as green tea (which contains epigallocatechin-3-gallate) (Bengmark et al., 2009; Mondal et al., 2012) and turmeric (which contains quercetin and berberine) (Mantena et al., 2006) . In this point of time, there is a need to evaluate the natural edible plant products and/or extract against the deadly disease cancer, to ease from the unwanted side effect.
Complementary and alternative medicine (CAM) is becoming increasingly popular particularly in oncology, which often applies various CAMs to give patients a better quality of living by alleviating their suffering (Chakraborty et al., 2013) . In Chinese medical treatment, mulberry extract has been traditionally used in the treatment of diabetic nephropathy and is popular for its antiadipogenic and anti-hyperglycemic effects (Gupta and Patel, 2013; Wang et al., 2014) . Insulin resistance has been shown to be improved by treatment with mulberry (Ren et al., 2015) . Other than that, MARE displays a profound anti-inflammatory effect on macrophages: a study has shown that LPS-induced inflammation can be reduced in RAW 264.7 cells through ERK1/2 activation in a ROS-dependent process (Eo et al., 2014) . In MCF-7 cells, MARE treatment reduced the viability of cancer cells and activated JNK1/2 pathway to induce apoptosis (Choi et al., 2013) . Albanol A, isolated from mulberry root, has been shown to promote apoptosis in leukaemia cells through disrupting Bax/Bcl-2 homeostasis and activating caspase 2 (Kikuchi et al., 2010) . Studies also showed that geranylated flavonoids isolated from mulberry root possess a cytotoxic effect on THP-1 monocytic leukaemia cells (Smejkal et al., 2010) . Another study on leukae-mia and melanoma showed that the water extract of mulberry root could disrupt the microtubule assembly of cancer cells; however, it could not arrest cells precisely at the G1 stage as taxol does (Nam et al., 2002) . Apart from the anticancer and anti-hyperglycaemic effects, one recent study pointed out that mulberry leaf polyphenols delayed the aging process and regulated fat metabolism in C. elegans (Zheng et al., 2014) . Mulberry also plays a protective role against different stresses; for example, it protects pancreatic E-cells from hydrogen peroxide via an anti-oxidant pathway .
The diverse activities of mulberry could make it a "wonder plant"; the protective activity of the mulberry could save the non-cancer cells, while killing the cancer cells. To elucidate the MARE's mechanism of action against neuroblastoma, we chose the B103 cell as a model cell line and different molecular pathways were studied with regard to cancer. The results suggest that MARE has a profound cytotoxic effect on B103 cells, but does not possess any toxicity against normal cells. The induction of ROS by MARE treatment damages the mitochondrial membrane potential and its downstream, caspase 3 localization into the nucleus. MARE also regulates FOXO3a translocation in an Akt-dependent manner. Overall, MARE could reduce proliferation and induce cell death by the reduction of Akt and induction of caspase 3 activity, respectively.
MATERIALS AND METHODS

Reagents
Dulbecco's Modified Eagle's Medium (DMEM), Fetal Bovine Serum (FBS), and Penicillin/Streptomycin were procured from GIBCO-BRL (USA). Antibodies against PI3K, p-PI3K, Akt, pAkt (Ser473), cleaved caspase-3, Bax, Bcl-2, p-Fox03A (Thr32), Fox03A, and E-actin were purchased from Cell Signaling Technology (USA) and anti-BIM was purchased from BD Bioscience.
Preparation of extract
Morus alba root was boiled with 70% ethanol at 100qC, and filtered. The filtrate was then concentrated in a desiccator at room temperature. The obtained powder was dissolved in dimethyl sulfoxide (DMSO) before treatment. Four different concentrations were used in the experiment: 5, 10, 15, and 20 Pg/ml.
Cell cultures
Rat B103 neuroblastoma and Rat-2 fibroblast cells were grown at 37qC under a humidified and ambient oxygen level in a CO incubator. Cells were cultured in DMEM containing 10% fetal bovine serum (FBS), 50 U/ml penicillin, and 50 Pg/ml streptomycin. The cells were trypsinized before harvest and subcultured.
Cell viability assay
Cell viability was determined using a cytotoxicity assay kit CCK-8 (Dojindo Lab, Japan), which was performed in accordance with the manufacturer's instructions. After treatment, cells were kept for incubation, as required by the experiment. A 96-well microtitre plate reader (Molecular Devices) was used to determine the absorbance at 450 nm.
Morphological analysis
For the cell morphology experiment, cells were grown in 6-well plate and treated with MARE. After 24 h of incubation, the cells were examined under a bright-field inverted microscope and digitally imaged.
DAPI staining
B103 cell were grown on glass cover-slips in a 24-well plate and treated with MARE. After the incubation, cells were fixed with 4% paraformaldehyde, followed by a wash with PBS. Cells were then stained with DAPI and observed under a DAPI filter by a fluorescence microscope.
Apoptosis analysis
B103 cells were grown and treated with MARE for 24 h. After incubation, cells were stained with annexin V and 7-AAD to determine apoptosis; with DCFDA to determine the ROS level; and with rhodamine 123 to measure the mitochondrial membrane potential. Stained cells analysed via flow cytometry (FACS Callibur, BD Bioscience) under their specific filters.
Indirect inter cellular staining: caspase 3 activity assay The caspase-3 activity assay was performed as per the manufacturer's protocol, using an anti-caspase primary antibody and a FITC-tagged secondary antibody. The fluorescence was determined by a flowcytometer using FL-1H filters. Data were analysed with Cyflogic software.
Immunocytochemistry
After treatment, cells were fixed with 4% paraformaldehyde. Following a PBS washing, cells were blocked with bovine serum albumin in PBS at room temperature. Cells were incubated overnight with a primary antibody at 4qC, and then they were washed with PBS, and incubated with the secondary antibody for 2 h at room temperature. Following another washing in PBS, the stained cover-slips were mounted and observed under fluorescence microscope.
Western blot
Cells were grown in a 60mm culture dish and treated various concentrations of MARE. After incubation, cells were lysed in a buffer containing 2% SDS, NaΎVOΏ and protease inhibitor cocktail. Equal amounts of proteins were separated by SDS-PAGE (8-15% reducing gels), transferred to polyvinylidene difluoride membranes (Millipore), and blocked with 5% non-fat milk. Membranes were incubated with a specific primary antibody and secondary antibody.
Statistical analysis
Results were expressed as mean r SEM. Statistical significance was analysed by t-test using Prism 5 (Graph pad Software). p < 0.05 was considered significant. All the experiments were repeated thrice and the reported values represent the mean values.
RESULTS
MARE reduces viability and proliferative potential of B103 cells without affecting Rat-2 cells' viability
To check whether MARE-treatment reduces viability, a cancerous cell line, B103, and a normal cell line, Rat-2, were chosen. Results of a viability assay revealed that the cancer cells' viability gradually reduces between minimal MARE concentrations (0.5 Pg/ml) and higher concentrations (10-20 Pg/ml), but that the same treatment against normal cells showed that MARE was not cytotoxic towards them (Fig. 1A) . At 10 Pg/ml of MARE, cells appeared to be growth-arrested, so to check this event, the anti-proliferative activity was further investigated by a CCK-8 assay. We found that MARE was able to reduce the proliferation of B103 cells (Fig. 1A) . The reduction of growth was promi-A B C nent after 12 h of drug treatment and proliferation gradually decreased as the incubation time increased in comparison with the control (vehicle/DMSO-treated) sets. Combining both the events, we suggest that MARE treatment could result in cytotoxicity, particularly toward neuroblastoma cells, while reducing their proliferation.
MARE induces differentiated cellular and nuclear morphology in B103 cells
The induction of cytotoxicity could bring upon morphological changes in the cells. To check for potential morphological alteration, different doses of MARE were applied to B103 cells and observed microscopically. Microscopic images of MARE-treated cells showed significant morphological changes as compared to the control cells. The treated cells showed a rounding of the cellular structure with the 'bleb' formation (Fig. 1B) . The nuclear morphology was observed by DAPI staining. The result of fluorescent microscopic images clearly demonstrated the condensation of nuclear chromatin with the pyknotic bodies formation (DAPI positive cells) (Fig. 1C) . The observation reveals that the MARE cytotoxicity in B103 cells leads to morphological changes within the cells, potentially a hallmark of apoptosis.
MARE treatment produces early apoptotic cells by involving caspase 3
A change in morphology with the induction of cytotoxicity was prominent when B103 cells were treated with MARE, representing the hallmark of apoptosis. We examined whether MARE-treated cell death was apoptotic. To do so, we stained the cells with annexin V and 7AAD. Annexin V binds with the phosphatidylserine (PS), under normal physiological conditions PS located in the inner leaflet of the plasma membrane. Upon induction of apoptosis, PS loses asymmetric distribution across the phospholipid bilayer and is translocated to the extracellular membrane leaflet. Once on the outer surface of the membrane, PS can be detected by fluorescently labelled Annexin V. In early-stage apoptosis, the plasma membrane excludes viability dye like 7-AAD. These cells will stain with Annexin V but not a viability dye, thus distinguishing cells in early apoptosis. In our result, flow cytometry data clearly indicated that there was a distinct formation of a population of cells in the annexin V positive-7AAD negative quadrant after MARE treatment ( Fig. 2A) . The population shift was greater toward that quadrant at the higher doses of MARE (Fig. 2B) . The result revealed that the cell death caused by MARE was early apoptosis.
To further investigate the possible signalling pathway associated with the apoptosis, we checked the activity, expression, and the localization of the caspase 3 protein by FACS, immunoblotting, and microscopy. Flow cytometry data suggested that MARE treatment increased caspase 3 activity, which was down-regulated when co-treated with a caspase 3 inhibitor (Z-DEVD-FMK) (Fig. 3A) . The results from a western blot also suggested that there was an up-regulation of expression in the treatment groups (~2.3 to ~2.4 folds) than in the control cells (Fig. 3B) . Fluorescent microscopic images revealed that activated caspase 3 protein was localized in the nucleus of the cancer cells (Fig. 3C) . By combining all of these results, we could predict that MARE treatment activates caspase Fig. 1. (A) To evaluate the cytotoxic effects of MARE in B103 rat neuroblastoma cells and Rat-2 rat fibroblast cells, we performed a cell viability assay using a cytotoxicity assay kit (CCK-8). Cells were exposed to different does of MARE (0 to 20 Pg/ml); 10 Pg/ml of MARE was used for the timedependent studies. Data are composed of the mean from three independent experiments in which the activity in the absence of MARE versus in the presence of MARE is significantly different (n = 4, *P < 0.05, ** < 0.01, *** < 0.001). (B) Cells were treated with different doses of MARE (0 to 20 Pg/ml). After 24 h, they were digitally photographed ( The activity of caspase-3 in MARE-treated cells was evaluated by flow cytometry using a caspase-3 antibody by indirect staining and the results indicate that, upon co-treatment of caspase-3 inhibitor (Z-DEVD-FMK) with MARE, the ability of MARE to activate caspase-3 is reduced.
3, which induces DNA damage and apoptosis.
MARE treatment generates reactive oxygen species in B103 cells
To examine the possible events in the induction of the apoptotic death pathway, we evaluated ROS generation in B103 cells after MARE treatment. ROS is a novel tool used to combat cancer, and it could create an apoptotic condition in the cancer cells when a threshold tolerance limit is crossed. Treated and control cells were stained with DCFDA and counted via flow cytometry. The control cells had the smallest amount of ROS in them, but the amount of ROS increased in a dose-dependent manner with MARE administration (Fig. 4A ). This observation shows that the increase in ROS inside the cells may damage the mitochondria membrane, depolarizing it to induce apoptosis.
MARE treatment depolarizes MMP and upsets the Bcl-2/Bax ratio
To check whether MARE treatment could depolarize the mitochondria membrane, we stained B103 cells with Rhodamine 123 and estimated mitochondrial membrane depolarization with flow cytometry. We found that, with MARE treatment, mitochondrial membrane depolarization increased in a dosedependent manner (Fig. 4B) . To evaluate the proteins responsible for this process, we further verified the expression of different Bcl-2 family proteins. With MARE treatment, antiapoptotic Bcl-2 expression decreased with an increase in Bax expression, and thus, the ratio between Bcl-2 and Bax was disrupted (Fig. 4C) . Consequently, we now propose that MARE possesses the capacity to induce apoptosis in neuroblastoma by inducing ROS and MMP depolarization, the process which results in caspase 3 activation.
MARE induced ROS plays the central role in controlling apoptosis and proliferation
To investigate the involvement of MARE induced ROS in controlling apoptosis and proliferation, we treated MARE on B103 cells in presence or absence of NAC (N-acetyl cysteine) and preformed annexin V assay, cell viability assay and proliferation assay. We found that in MARE and NAC co-treated samples, the formation of annexin V positive cells downed to the normal level (Fig. 5A) . The similar kind of result was observed in the viability assay. We found that in NAC/MARE co-treated B103 cells, viability was increased further and became at per with the MANE-untreated B103 cells (Fig. 5B ). In the proliferation assay result we found that the co-treatment of NAC with MARE treatment resist the effectiveness of MARE on proliferation (Fig. 5C ). By combining all the findings, we can proposed that MARE induced ROS accumulation further controls the process of apoptosis induction and proliferation reduction.
MARE treatment modulates proliferation and transcription markers
Akt is constitutively dynamic in most cancer cells, and it enhances cell proliferation. In order to understand the association between PI3K/Akt and MARE-induced growth inhibition, here, we determined the expression of protein phosphorylation of PI3K and Akt in cells exposed to MARE. MARE resulted in slight inhibition of phosphorylation of PI3K (Tyr458) and completely blocked phosphorylation of PI3K (Tyr199) in B103 cells (Fig. 6A ) and relatively marked inhibition of Akt phosphorylation (Fig. 6A) . MARE had no effect on total PI3K and Akt expression (Fig. 6A) . These results suggested that MARE-mediated Akt signaling inhibition may contribute to growth inhibition of B103 cells. However, the phosphorylation of FOXO3a proteins was analysed using western blotting. MARE inhibited the phosphorylation of FOXO3a protein. Conversely, MARE-treatment has dose-dependently increased on the total protein of FOXO3a expression (Fig. 6A) . These results suggested that MARE inhibited growth by regulating FOXO3a and suggesting FOXO3a may be associated with kinase activity. At the same time, MARE caused a very clear upregulation of Bim levels in the B103 cells (Fig. 6A) . Further, we checked the localization of FOXO3a with fluorescence microscopy and the results indicated that FOXO3a was located inside the nucleus (Fig. 6B) . Therefore, the translocation of FOXO factors into the nucleus from cytoplasm activates apoptosis signals through upregulating BIM activity (Myatt and Lam, 2007) . Taken together, these results suggest that FOXO3a may be a novel downstream way of MARE-treatment against B103 cells.
DISCUSSION
The present study reports the anti-cancer effects of MARE against neuroblastoma. We observed that MARE elicited the upregulation of caspase 3 activity and the down-regulation of Akt and FOXO3a phosphorylation. The blocking of growth inductive signals and induction of ROS by the drug induced a rapid apoptotic response in the neuroblastoma-B103 cells. These included morphological changes that occurred within 24 h of MARE administration, with progressive detachment of cells containing condensed and fragmented chromatin. The results also suggest that the viability of cancer cells is reduced in a dose-dependent manner. MARE's interference with the mitochondria membrane and caspase-mediated apoptosis through a disruption of the Bcl-2/Bax ratio further confirms MARE's apoptosis-inducing capability in neuroblastoma cells. MARE shows a relative low toxicity toward non-cancerous cells, which suggests that MARE could be an effective and safe anticancer drug. Although a study on multi-drug resistant breast cancer and leukaemia with MARE indicated that MARE plays an effective role in inducing the JNK pathway (Choi et al., 2013) , resulting in the induction of apoptosis, but there is a lack of knowledge about the activities of MARE on neuroblastoma. The purpose of this study was to investigate the probable mechanisms of MARE's toxicity against neuroblastoma cells.
The mulberry plant has been reported to be rich in flavonoids that have different biological activities, including its anti-oxidant capacity (Zheng et al., 2014) . In this study, MARE treatment of B103 cells was found to stimulate ROS accumulation and further depolarize the MMP. Studies on ROS reveal that its exposure beyond the tolerated limit usually pushes cancer cells towards apoptosis by disrupting mitochondrial integrity (Huang et al., 2014) . Recent reports have demonstrated dramatic alterations in mitochondrial morphology during the early stages of apoptotic cell death, including a fragmentation of the network and the remodelling of the cristae (Suen et al., 2008) . Surprisingly, proteins discovered to control mitochondrial morphology appear to also participate in apoptosis and proteins associated with the regulation of apoptosis have been shown to affect mitochondrial ultra-structure (Karbowski and Youle, 2003) . Bax translocation to the mitochondrial membrane creates a pore, which otherwise depolarize the mitochondria membrane potential (Henry-Mowatt et al., 2004) . Members of the Bcl-2 family proteins are known to play a critical regulatory role in the apoptosis pathway (Martinou and Youle, 2011) . Bcl-2 has been shown to form a heterodimer with pro-apoptotic Bax, a union which may neutralize its proapoptotic effect (Moldoveanu et al., 2014) . Therefore, an alteration in the levels of Bcl-2 and Bax could be a decisive factor in the induction of apoptotic conditions in cells. In our study, Bax expression increased while Bcl-2 expression decreased with MARE treatment, thus disrupting the balance between them, which is a major event in the initiation of apoptosis involving the mitochondria. Through this distorted mitochondrial membrane, cytochrome c is released out to the cytosol of the cells (Chipuk et al., 2006) and initiates the formation of an apoptosome along with the adopter molecule Apaf-1 and other pro-caspase molecules like caspase-9 and 3 (Tait and Green, 2010) . Downstream, activated caspase 3 induces chromatin condensation and degradation through nick formation (Kitazumi and Tsukahara, 2011) . The activated caspase 3 and presence of DAPI-positive cells in the MARE treated samples, is a clear indicator of the induction of apoptosis involving mitochondria and caspase 3.
The anti-neoplastic effect of a drug could also diminish the propagative potential of cancer cells along with the reduction of different growth signals and prevention of specific transcriptions (Hanahan and Weinberg, 2011) . Akt and FOXO-family proteins are two distinct agents that control cancer growth and metastasis (Boreddy et al., 2011) . Class I PI3K protein is responsible to control the process of Akt phosphorylation and activation. The class 1 PI3K is composed of a heterodimer between p110 catalytic subunit and a p85 regulatory subunit and there are different variants of the p85 regulatory subunit, one among them is p55. Phosphorylation on p55 regulatory region alternatively controls the activity of pI3K enzyme. Reduction in phosphorylation on p55 region of PI3K in turn indicated the conquest of its activity (Carpenter et al., 1990) . The inhibitory effects of MARE on neuroblastoma growth not only resulted from caspase 3 activation, but also through the de-activation of PI3K and Akt. Phosphorylation at different serine and threonine sites of Akt contributes to its activation (Wang and Basson, 2011) . Phosphorylation at Ser473 of Akt by PI3K is responsible for the activation and membrane attachment of Akt, causing the acceleration of downstream growth signals (Wang and Basson, 2011) . MARE treatment reduces the phosphorylation events of Akt protein, and thus rendering it irrelevant for growth signal induction.
Proliferation via different growth signals involves the process of transcription and activated transcription factors. FOXO3a, a known transcription factor, is a direct downstream molecule of Akt (Zhang et al., 2011) . Transcriptional activity and localization of FOXO3a is regulated by Akt. Akt-mediated phosphorylation of FOXO3a is located in the cytoplasm. However, inactivation of Akt leads to the de-phosphorylation of FOXO3, activating it (Brunet et al., 1999) . Accordingly, FOXO3a translocate into the nucleus and where it increases the transcriptional activity of its target gene, the apoptotic protein, Bim (Myatt and Lam, 2007) . So, the activation of FOXO3a triggers apoptosis through its regulation of Bim activity. MARE treatment on neuroblastoma cells supports the same phenomenon (Fig. 7) .
In conclusion, we explored the anticancer potential of MARE against neuroblastoma, finding evidence that it possesses considerable anticancer potential in addition to its anti-diabetic properties. We found that the apoptotic pathway linked to the mitochondria-dependent caspase route, through caspase 3 activation, resulting in the death of the cancer cells occurred with the administration of MARE. De-phosphorylation of Akt and FOXO3a with MARE treatment makes the cancer cells anti-proliferative. The dual role played by this drug could be of interest in the design and formulation of specialized drugs.
